Taken together with previous studies indicating a vasculoprotective role of cav-1 and caveolae [22, 82–84], our in vitro and in vivo findings suggest that atheroprone flow can lead to endothelial dysfunction through decreased cav-1/caveolae expression and localization. The gene discussed is CAV1; the disease is endothelial dysfunction.